Table 5. Estimation of the effects of WhiteRace, Age and Treatment for the HVTN 502 Step HIV vaccine efficacy trial data.
WhiteRace | Age | Treatment | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
Method | EST |
|
P-value | EST |
|
P-value | EST |
|
P-value | |||
CC | -0.460 | 0.403 | 0.254 | 0.040 | 0.013 | 0.002 | -0.743 | 0.152 | 0.000 | |||
IPW | -0.501 | 0.402 | 0.213 | 0.039 | 0.013 | 0.002 | -0.681 | 0.167 | 0.000 | |||
EEI | -0.321 | 0.428 | 0.453 | 0.022 | 0.013 | 0.084 | -0.786 | 0.132 | 0.000 | |||
AIPW | -0.296 | 0.426 | 0.488 | 0.024 | 0.013 | 0.064 | -0.772 | 0.132 | 0.000 |